3 Reasons Moderna Stock Is a Bargain Right Now
Over the past two years, a question that often popped up was: Is Moderna (NASDAQ: MRNA) stock too expensive? That's because of the biotech company's enormous gains over that time period. It soared 1,200%. Investors initially bet on its ability to bring a coronavirus vaccine to market. Then, they stuck around -- and many more joined them -- as the vaccine generated billions of dollars in revenue and profit.
In recent days, though, Moderna stock has stumbled. That's because some investors worry about vaccine revenue in a post-pandemic world. But I think there's a lot more ahead for Moderna stock. And that means it's a bargain at today's level. Here are three reasons why.
Image source: Getty Images.
Source Fool.com
